Clinical trial registry record

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registry ID
NCT06975111
Last registry update
July 21, 2026
Status
Recruiting
Phase
PHASE2, PHASE3
Sponsor
University of Colorado, Denver
Enrollment
200
Countries
United States
Match confidence
62%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE2, PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record matched · 62% confidence

Source terminology contains: semaglutide.

  • GLP-1 therapies · 62%Source terminology contains: semaglutide. Abstract supplies longevity context: aging, healthspan. Study type is explicitly identified as INTERVENTIONAL.
  • Metformin · 62%Source terminology contains: metformin. Abstract supplies longevity context: aging, healthspan. Study type is explicitly identified as INTERVENTIONAL.

Source quality 100% · freshness 100%. These are automated routing signals, not medical or evidence-strength ratings.

glp 1 therapiesmetformin
Open primary sourceExport JSON